Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yanming Zhang

Showing results (391-400 of 459) with videos related to

Pageof 46
Sort By:
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|August 9, 2023
HER2 Genetic Intratumor Heterogeneity Is Associated With Resistance to Trastuzumab and Trastuzumab Emtansine Therapy in Recurrent High-Grade Endometrial CancerSherry Shen, Weining Ma, David Brown, et al.
The American Journal of Surgical Pathology|September 5, 2020
Genomic Profiling Aids Classification of Diagnostically Challenging Uterine Mesenchymal Tumors With Myomelanocytic DifferentiationPier Selenica, Niamh Conlon, Carlene Gonzalez, et al.
Cancer|May 15, 2023
Obesity in adult acute myeloid leukemia is not associated with inferior response or survival even when dose capping anthracyclines: An ECOG-ACRIN analysisJames M Foran, Zhuoxin Sun, Catherine Lai, et al.
Therapeutic Advances in Medical Oncology|June 17, 2024
Hetrombopag for the management of chemotherapy-induced thrombocytopenia in patients with advanced solid tumors: a multicenter, randomized, double-blind, placebo-controlled, phase II studyShukui Qin, Yusheng Wang, Jun Yao, et al.
Nature Materials|August 27, 2025
High-quality narrow black phosphorus nanoribbons with nearly atomically smooth edges and well-defined edge orientationTeng Zhang, Youxin Chen, Zhiyan He, et al.
Blood|January 15, 2025
Defining 2 biologically and clinically distinct groups in acute leukemia with a mixed phenotypePallavi Galera, Deepika Dilip, Andriy Derkach, et al.
Leukemia Research|November 4, 2022
Measurable residual disease by flow cytometry in acute myeloid leukemia is prognostic, independent of genomic profilingChezi Ganzel, Zhuoxin Sun, Timour Baslan, et al.
Blood Cancer Journal|February 1, 2020
Correction: Comprehensive detection of recurring genomic abnormalities: a targeted sequencing approach for multiple myelomaVenkata Yellapantula, Malin Hultcrantz, Even H Rustad, et al.
Signal Transduction and Targeted Therapy|March 20, 2025
Efficacy and safety of KN026, a bispecific anti-HER2 antibody, in combination with KN046, an anti-CTLA4/PD-L1 antibody, in patients with advanced HER2-positive nonbreast cancer: a combined analysis of a phase Ib and a phase II studyDan Liu, Jifang Gong, Jian Li, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 5, 2009
Pomalidomide is active in the treatment of anemia associated with myelofibrosisAyalew Tefferi, Srdan Verstovsek, Giovanni Barosi, et al.
Pageof 46

Showing results (391-400 of 459) with videos related to

Sort By:
Pageof 46
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|August 9, 2023
HER2 Genetic Intratumor Heterogeneity Is Associated With Resistance to Trastuzumab and Trastuzumab Emtansine Therapy in Recurrent High-Grade Endometrial CancerSherry Shen, Weining Ma, David Brown, et al.
The American Journal of Surgical Pathology|September 5, 2020
Genomic Profiling Aids Classification of Diagnostically Challenging Uterine Mesenchymal Tumors With Myomelanocytic DifferentiationPier Selenica, Niamh Conlon, Carlene Gonzalez, et al.
Cancer|May 15, 2023
Obesity in adult acute myeloid leukemia is not associated with inferior response or survival even when dose capping anthracyclines: An ECOG-ACRIN analysisJames M Foran, Zhuoxin Sun, Catherine Lai, et al.
Therapeutic Advances in Medical Oncology|June 17, 2024
Hetrombopag for the management of chemotherapy-induced thrombocytopenia in patients with advanced solid tumors: a multicenter, randomized, double-blind, placebo-controlled, phase II studyShukui Qin, Yusheng Wang, Jun Yao, et al.
Nature Materials|August 27, 2025
High-quality narrow black phosphorus nanoribbons with nearly atomically smooth edges and well-defined edge orientationTeng Zhang, Youxin Chen, Zhiyan He, et al.
Blood|January 15, 2025
Defining 2 biologically and clinically distinct groups in acute leukemia with a mixed phenotypePallavi Galera, Deepika Dilip, Andriy Derkach, et al.
Leukemia Research|November 4, 2022
Measurable residual disease by flow cytometry in acute myeloid leukemia is prognostic, independent of genomic profilingChezi Ganzel, Zhuoxin Sun, Timour Baslan, et al.
Blood Cancer Journal|February 1, 2020
Correction: Comprehensive detection of recurring genomic abnormalities: a targeted sequencing approach for multiple myelomaVenkata Yellapantula, Malin Hultcrantz, Even H Rustad, et al.
Signal Transduction and Targeted Therapy|March 20, 2025
Efficacy and safety of KN026, a bispecific anti-HER2 antibody, in combination with KN046, an anti-CTLA4/PD-L1 antibody, in patients with advanced HER2-positive nonbreast cancer: a combined analysis of a phase Ib and a phase II studyDan Liu, Jifang Gong, Jian Li, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 5, 2009
Pomalidomide is active in the treatment of anemia associated with myelofibrosisAyalew Tefferi, Srdan Verstovsek, Giovanni Barosi, et al.
Pageof 46